newsfilter
← Latest News
PR Newswire·

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called...